GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice
Journal of Peptide Science 23(12):845–854, 2017
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues
Journal of Medicinal Chemistry 60(17):7434–7446, 2017
A hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
ACS Chemical Biology 12(8):2107–2116, 2017
Neoglycolipids for prolonging the effects of peptides: Self-assembling glucagon-like peptide 1 analogues with albumin binding properties and potent in vivo efficacy
Molecular Pharmacology 14(1):193–205, 2017
Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass
Molecular Metabolism 5(4):296-304, 2016
Neuromedin U inhibits food intake partly by inhibiting gastric emptying
Peptides 69:56–65, 2015
Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake
Journal of Peptide Science 21(2):85–94, 2015
The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat
European Journal of Pharmacology 741:254-263, 2014